Cellectar Biosciences, Inc. (NASDAQ:CLRB) Sees Large Drop in Short Interest

Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) was the target of a significant decline in short interest in August. As of August 15th, there was short interest totalling 2,550,000 shares, a decline of 10.2% from the July 31st total of 2,840,000 shares. Approximately 7.4% of the company’s stock are short sold. Based on an […]

Leave a Reply

Your email address will not be published.

Previous post Esperion Therapeutics, Inc. (NASDAQ:ESPR) Sees Large Increase in Short Interest
Next post CureVac (NASDAQ:CVAC) Short Interest Down 10.0% in August